Mdma molecule:

Image from PubChem

Mdma Clinical Trials


The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05570708

Organisation Name: University Hospital, Basel, Switzerland

Overal Status: Not yet recruiting

Start Date: December 1, 2022

Last Update: October 7, 2022

Lead Sponsor: Felix Mueller

Brief Summary: The study investigates two groups of participants of the SÄPT therapist's training starting in October 2022. The overall objective is to investigate the risks and benefits of personal experience (PE) with substance-induced altered states of consciousness for physicians or psychotherapists in the context of a training course for substance-assisted therapy. Specifically, the study aims to assess changes in therapeutic attitude and other factors important in interactions between patients and therapists (such as empathy and cognitive flexibility).

Conditions:
  • Personal Experience of Substance-assisted Therapy Using Psilocybin, MDMA, and LSD


Total execution time in seconds: 0.31278586387634